FREE SHIPPING over $40
OVER 10000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Canadian journal of veterinary research = Revue canadienne de recherche veterinaire2016; 80(4); 294-301;

Evaluation of adipose-derived stromal vascular fraction from the lateral tailhead, inguinal region, and mesentery of horses.

Abstract: Use of mesenchymal stem cells (MSCs) found in the stromal vascular fraction (SVF) of equine adipose tissue has promising applications for regenerative therapies. The most commonly used source of equine adipose tissue is the subcutaneous tailhead. The objective of this study was to compare 3 adipose depot sites in horses and determine the viability and cellular yield, capillary density, gene expression for selected markers, and colony-forming unit fibroblasts (CFU-Fs) in adipose tissue taken from these sites. Adipose tissue was excised from the area lateral to the tailhead, the inguinal region, and the small colon mesentery of 6 horses. Lipoaspirate was also collected from the area lateral to the tailhead. Stromal vascular fraction (SVF) was prepared in duplicate from the 3 different adipose tissue depots. The total nucleated and dead cell counts was determined manually using a hemocytometer and percent viability was calculated. Mass and volume of adipose were determined in order to calculate density and factor-VIII immunohistochemical staining was used to determine vascular density in the excisional adipose tissue samples from each horse. Quantitative polymerase chain reaction (qPCR) was used to quantify gene expression for selected cellular markers from each site. There were significant differences in viability, yield of nucleated cells/gram of adipose tissue, vascular density, gene expression, and CFU-Fs among adipose depots. Adipose from the mesentery yielded the highest number of nucleated cells/gram of tissue and the highest vascular density and percentage of CFU-Fs. In the horse, both the anatomical site of collection and the method of tissue collection significantly impact the yield and composition of cells in the SVF. Further study is needed to assess whether one adipose source is superior for harvesting mesenchymal stem cells (MSCs) and whether the differences among sources are clinically relevant for treatment of musculoskeletal injuries in horses. L’utilisation de cellules souches mésenchymateuses (CSMs) retrouvées dans la fraction du stroma vasculaire (FSV) du tissu adipeux équin a des applications prometteuses pour les thérapies régénératrices. La source la plus fréquemment utilisée de tissu adipeux équin est le tissu sous-cutané de la base de la queue. L’objectif de la présente étude était de comparer trois sites de dépôts adipeux chez le cheval et de déterminer la viabilité et la récolte cellulaire, la densité capillaire, l’expression génique de marqueurs sélectionnés, et le nombre de fibroblastes formateur des colonies (FFC) dans le tissu adipeux prélevés de ces sites. Le tissu adipeux a été excisé de la région latérale à la base de la queue, de la région inguinale, et du mésentère du petit colon de six chevaux. Des aspirations de lipide ont également été prélevées de la région latérale de la base de la queue. La FSV a été préparée en duplicata à partir de chacun des trois dépôts différents de tissu adipeux. Les dénombrements totaux des cellules nucléées et mortes ont été déterminés manuellement à l’aide d’un hémocytomètre et le pourcentage de viabilité calculé. La masse et le volume de tissu adipeux ont été déterminés afin de calculer la densité et la coloration par immunohistochimie du facteur VIII a été utilisée afin de déterminer la densité vasculaire dans les échantillons de tissu adipeux excisé de chaque cheval. Une réaction d’amplification en chaine par la polymérase quantitative (ACPq) a été utilisée pour quantifier l’expression génique pour des marqueurs cellulaires sélectionnés de chaque site. Il y avait des différences significatives dans la viabilité, le rendement de cellules nucléées/gramme de tissu adipeux, la densité vasculaire, l’expression génique, et les FFCs entre les dépôts adipeux. Le tissu adipeux provenant du mésentère a généré le plus grand nombre de cellules nucléées/gramme de tissu et la plus haute densité vasculaire et pourcentage de FFCs. Chez le cheval, le site anatomique de prélèvement et la méthode de prélèvement du tissu ont un impact significatif sur le rendement et la composition cellulaire dans la FSV. Des études additionnelles sont requises pour évaluer si une source de tissu adipeux est supérieure pour récolter des cellules souches mésenchymateuses et si les différences entre les sources sont cliniquement pertinentes pour le traitement de blessures morpho-squelettiques chez les chevaux.(Traduit par Docteur Serge Messier).
Get Full Text
Publication Date: 2016-10-14 PubMed ID: 27733784PubMed Central: PMC5052881
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research dives into the potential of using mesenchymal stem cells (MSCs) from horse adipose tissue for regenerative therapies. It examines three different areas of fat collection in the horse’s body and assesses the viability, cellular yield, capillary density, and gene expression, concluding that the method and location of the adipose extraction significantly influence the success of the procedure.

Objective and Methodology

  • The objective of the study was to analyze the stromal vascular fraction (SVF), a rich source of mesenchymal stem cells (MSCs), extracted from adipose tissues in different areas of six horses’ bodies.
  • The adipose tissues were collected from three distinct locations – the area lateral to the tailhead, the inguinal region, and the small colon mesentery.
  • Alongside excision, lipoaspiration was also performed on the area lateral to the tailhead.
  • The techniques used to evaluate the samples included quantitative polymerase chain reaction (qPCR) to assess gene expression, factor-VIII immunohistochemical staining to determine vascular density, and hemocytometer to evaluate total nucleated and dead cell counts.

Results and Findings

  • All adipose depot sites showed differing results in terms of viability, cellular yield, vascular density, gene expression, and percentage of colony-forming unit fibroblasts (CFU-Fs).
  • The adipose tissue from the mesentery yielded the highest number of nucleated cells per gram of tissue, the highest vascular density and the highest percentage of CFU-Fs, indicating it to be the most efficient site for MSCs extraction.

Impact and Recommendations

  • The results highlight the crucial role of the collection site and method in harvesting useful MSCs from the SVF of horse adipose tissues.
  • The findings could be significant for the development of new regenerative therapies focusing on stem cells derived from adipose tissues.
  • Further research should address if one adipose source is better than others in MSCs collection and study the potential clinical relevance in treating musculoskeletal injuries in horses.

Cite This Article

APA
Metcalf GL, McClure SR, Hostetter JM, Martinez RF, Wang C. (2016). Evaluation of adipose-derived stromal vascular fraction from the lateral tailhead, inguinal region, and mesentery of horses. Can J Vet Res, 80(4), 294-301.

Publication

Canadian journal of veterinary research = Revue canadienne de recherche veterinaire
ISSN: 1928-9022
NlmUniqueID: 8607793
Country: Canada
Language: English
Volume: 80
Issue: 4
Pages: 294-301

Researcher Affiliations

Metcalf, Garrett L
  • Department of Veterinary Clinical Sciences (Metcalf, McClure), Department of Pathology (Hostetter), Department of Diagnostics and Production Animal Medicine and Department of Statistics (Wang), Iowa State University, Ames, Iowa, USA; InGeneron Inc., 8205 El Rio, Houston, Texas, USA (Martinez).
McClure, Scott R
  • Department of Veterinary Clinical Sciences (Metcalf, McClure), Department of Pathology (Hostetter), Department of Diagnostics and Production Animal Medicine and Department of Statistics (Wang), Iowa State University, Ames, Iowa, USA; InGeneron Inc., 8205 El Rio, Houston, Texas, USA (Martinez).
Hostetter, Jesse M
  • Department of Veterinary Clinical Sciences (Metcalf, McClure), Department of Pathology (Hostetter), Department of Diagnostics and Production Animal Medicine and Department of Statistics (Wang), Iowa State University, Ames, Iowa, USA; InGeneron Inc., 8205 El Rio, Houston, Texas, USA (Martinez).
Martinez, Rudy F
  • Department of Veterinary Clinical Sciences (Metcalf, McClure), Department of Pathology (Hostetter), Department of Diagnostics and Production Animal Medicine and Department of Statistics (Wang), Iowa State University, Ames, Iowa, USA; InGeneron Inc., 8205 El Rio, Houston, Texas, USA (Martinez).
Wang, Chong
  • Department of Veterinary Clinical Sciences (Metcalf, McClure), Department of Pathology (Hostetter), Department of Diagnostics and Production Animal Medicine and Department of Statistics (Wang), Iowa State University, Ames, Iowa, USA; InGeneron Inc., 8205 El Rio, Houston, Texas, USA (Martinez).

MeSH Terms

  • Adipose Tissue / cytology
  • Animals
  • Cell Survival / physiology
  • Colony-Forming Units Assay
  • Fibroblasts / physiology
  • Gene Expression Regulation
  • Horses
  • Immunohistochemistry
  • Mesenchymal Stem Cells / physiology
  • Tissue and Organ Harvesting / veterinary

References

This article includes 39 references
  1. Dyson SJ. Medical management of superficial digital flexor tendonitis: a comparative study in 219 horses (1992-2000).. Equine Vet J 2004 Jul;36(5):415-9.
    pubmed: 15253082doi: 10.2746/0425164044868422google scholar: lookup
  2. Avella CS, Ely ER, Verheyen KL, Price JS, Wood JL, Smith RK. Ultrasonographic assessment of the superficial digital flexor tendons of National Hunt racehorses in training over two racing seasons.. Equine Vet J 2009 May;41(5):449-54.
    pubmed: 19642404doi: 10.2746/042516409x391042google scholar: lookup
  3. Ross MW, Genovese RL, Dyson SJ, Jorgensen JS. Superficial digital flexor tendonitis.. 2011. pp. 706–726.
  4. Pacini S, Spinabella S, Trombi L, Fazzi R, Galimberti S, Dini F, Carlucci F, Petrini M. Suspension of bone marrow-derived undifferentiated mesenchymal stromal cells for repair of superficial digital flexor tendon in race horses.. Tissue Eng 2007 Dec;13(12):2949-55.
    pubmed: 17919069doi: 10.1089/ten.2007.0108google scholar: lookup
  5. Smith RK. Mesenchymal stem cell therapy for equine tendinopathy.. Disabil Rehabil 2008;30(20-22):1752-8.
    pubmed: 18608378doi: 10.1080/09638280701788241google scholar: lookup
  6. Godwin EE, Young NJ, Dudhia J, Beamish IC, Smith RK. Implantation of bone marrow-derived mesenchymal stem cells demonstrates improved outcome in horses with overstrain injury of the superficial digital flexor tendon.. Equine Vet J 2012 Jan;44(1):25-32.
    pubmed: 21615465doi: 10.1111/j.2042-3306.2011.00363.xgoogle scholar: lookup
  7. Renzi S, Riccò S, Dotti S, Sesso L, Grolli S, Cornali M, Carlin S, Patruno M, Cinotti S, Ferrari M. Autologous bone marrow mesenchymal stromal cells for regeneration of injured equine ligaments and tendons: a clinical report.. Res Vet Sci 2013 Aug;95(1):272-7.
    pubmed: 23419936doi: 10.1016/j.rvsc.2013.01.017google scholar: lookup
  8. Fraser JK, Wulur I, Alfonso Z, Hedrick MH. Fat tissue: an underappreciated source of stem cells for biotechnology.. Trends Biotechnol 2006 Apr;24(4):150-4.
    pubmed: 16488036doi: 10.1016/j.tibtech.2006.01.010google scholar: lookup
  9. Riordan NH, Ichim TE, Min WP, Wang H, Solano F, Lara F, Alfaro M, Rodriguez JP, Harman RJ, Patel AN, Murphy MP, Lee RR, Minev B. Non-expanded adipose stromal vascular fraction cell therapy for multiple sclerosis.. J Transl Med 2009 Apr 24;7:29.
    pmc: PMC2679713pubmed: 19393041doi: 10.1186/1479-5876-7-29google scholar: lookup
  10. Gentile P, Orlandi A, Scioli MG, Di Pasquali C, Bocchini I, Cervelli V. Concise review: adipose-derived stromal vascular fraction cells and platelet-rich plasma: basic and clinical implications for tissue engineering therapies in regenerative surgery.. Stem Cells Transl Med 2012 Mar;1(3):230-6.
    pmc: PMC3659840pubmed: 23197782doi: 10.5966/sctm.2011-0054google scholar: lookup
  11. Strem BM, Hicok KC, Zhu M, Wulur I, Alfonso Z, Schreiber RE, Fraser JK, Hedrick MH. Multipotential differentiation of adipose tissue-derived stem cells.. Keio J Med 2005 Sep;54(3):132-41.
    pubmed: 16237275doi: 10.2302/kjm.54.132google scholar: lookup
  12. Frisbie DD, Smith RK. Clinical update on the use of mesenchymal stem cells in equine orthopaedics.. Equine Vet J 2010 Jan;42(1):86-9.
    pubmed: 20121921doi: 10.2746/042516409x477263google scholar: lookup
  13. Strioga M, Viswanathan S, Darinskas A, Slaby O, Michalek J. Same or not the same? Comparison of adipose tissue-derived versus bone marrow-derived mesenchymal stem and stromal cells.. Stem Cells Dev 2012 Sep 20;21(14):2724-52.
    pubmed: 22468918doi: 10.1089/scd.2011.0722google scholar: lookup
  14. Kol A, Walker NJ, Galuppo LD, Clark KC, Buerchler S, Bernanke A, Borjesson DL. Autologous point-of-care cellular therapies variably induce equine mesenchymal stem cell migration, proliferation and cytokine expression.. Equine Vet J 2013 Mar;45(2):193-8.
    pubmed: 22780195doi: 10.1111/j.2042-3306.2012.00600.xgoogle scholar: lookup
  15. Adams MK, Goodrich LR, Rao S, Olea-Popelka F, Phillips N, Kisiday JD, McIlwraith CW. Equine bone marrow-derived mesenchymal stromal cells (BMDMSCs) from the ilium and sternum: are there differences?. Equine Vet J 2013 May;45(3):372-5.
    pmc: PMC3581704pubmed: 23009322doi: 10.1111/j.2042-3306.2012.00646.xgoogle scholar: lookup
  16. da Silva Meirelles L, Sand TT, Harman RJ, Lennon DP, Caplan AI. MSC frequency correlates with blood vessel density in equine adipose tissue.. Tissue Eng Part A 2009 Feb;15(2):221-9.
    pmc: PMC2810211pubmed: 18847356doi: 10.1089/ten.tea.2008.0103google scholar: lookup
  17. Burk J, Ribitsch I, Gittel C, Juelke H, Kasper C, Staszyk C, Brehm W. Growth and differentiation characteristics of equine mesenchymal stromal cells derived from different sources.. Vet J 2013 Jan;195(1):98-106.
    pubmed: 22841420doi: 10.1016/j.tvjl.2012.06.004google scholar: lookup
  18. Bruno I, Martinez R, Sanchez A, Friddle C, McClure SR. Characterization of nucleated cells from equine adipose tissue and bone marrow aspirate processed for point-of-care use.. J Equine Vet Sci 2014;34:1118–1127.
  19. Russo V, Yu C, Belliveau P, Hamilton A, Flynn LE. Comparison of human adipose-derived stem cells isolated from subcutaneous, omental, and intrathoracic adipose tissue depots for regenerative applications.. Stem Cells Transl Med 2014 Feb;3(2):206-17.
    pmc: PMC3925056pubmed: 24361924doi: 10.5966/sctm.2013-0125google scholar: lookup
  20. Braun J, Hack A, Weis-Klemm M, Conrad S, Treml S, Kohler K, Walliser U, Skutella T, Aicher WK. Evaluation of the osteogenic and chondrogenic differentiation capacities of equine adipose tissue-derived mesenchymal stem cells.. Am J Vet Res 2010 Oct;71(10):1228-36.
    pubmed: 20919912doi: 10.2460/ajvr.71.10.1228google scholar: lookup
  21. Banyard DA, Salibian AA, Widgerow AD, Evans GR. Implications for human adipose-derived stem cells in plastic surgery.. J Cell Mol Med 2015 Jan;19(1):21-30.
    pmc: PMC4288346pubmed: 25425096doi: 10.1111/jcmm.12425google scholar: lookup
  22. Oedayrajsingh-Varma MJ, van Ham SM, Knippenberg M, Helder MN, Klein-Nulend J, Schouten TE, Ritt MJ, van Milligen FJ. Adipose tissue-derived mesenchymal stem cell yield and growth characteristics are affected by the tissue-harvesting procedure.. Cytotherapy 2006;8(2):166-77.
    pubmed: 16698690doi: 10.1080/14653240600621125google scholar: lookup
  23. Caplan AI. The mesengenic process.. Clin Plast Surg 1994 Jul;21(3):429-35.
    pubmed: 7924141
  24. Bourin P, Bunnell BA, Casteilla L, Dominici M, Katz AJ, March KL, Redl H, Rubin JP, Yoshimura K, Gimble JM. Stromal cells from the adipose tissue-derived stromal vascular fraction and culture expanded adipose tissue-derived stromal/stem cells: a joint statement of the International Federation for Adipose Therapeutics and Science (IFATS) and the International Society for Cellular Therapy (ISCT).. Cytotherapy 2013 Jun;15(6):641-8.
    pmc: PMC3979435pubmed: 23570660doi: 10.1016/j.jcyt.2013.02.006google scholar: lookup
  25. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop Dj, Horwitz E. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement.. Cytotherapy 2006;8(4):315-7.
    pubmed: 16923606doi: 10.1080/14653240600855905google scholar: lookup
  26. Kolf CM, Cho E, Tuan RS. Mesenchymal stromal cells. Biology of adult mesenchymal stem cells: regulation of niche, self-renewal and differentiation.. Arthritis Res Ther 2007;9(1):204.
    pmc: PMC1860068pubmed: 17316462doi: 10.1186/ar2116google scholar: lookup
  27. Stewart MC, Stewart AA. Mesenchymal stem cells: characteristics, sources, and mechanisms of action.. Vet Clin North Am Equine Pract 2011 Aug;27(2):243-61.
    pubmed: 21872757doi: 10.1016/j.cveq.2011.06.004google scholar: lookup
  28. Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, Sole J, Nichols A, Ross JS, Tartaglia LA, Chen H. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance.. J Clin Invest 2003 Dec;112(12):1821-30.
    pmc: PMC296998pubmed: 14679177doi: 10.1172/jci19451google scholar: lookup
  29. Ratajczak MZ, Zuba-Surma EK, Wysoczynski M, Ratajczak J, Kucia M. Very small embryonic-like stem cells: characterization, developmental origin, and biological significance.. Exp Hematol 2008 Jun;36(6):742-51.
    pmc: PMC2430762pubmed: 18474305doi: 10.1016/j.exphem.2008.03.010google scholar: lookup
  30. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr. Obesity is associated with macrophage accumulation in adipose tissue.. J Clin Invest 2003 Dec;112(12):1796-808.
    pmc: PMC296995pubmed: 14679176doi: 10.1172/jci19246google scholar: lookup
  31. Radcliffe CH, Flaminio MJ, Fortier LA. Temporal analysis of equine bone marrow aspirate during establishment of putative mesenchymal progenitor cell populations.. Stem Cells Dev 2010 Feb;19(2):269-82.
    pmc: PMC3138180pubmed: 19604071doi: 10.1089/scd.2009.0091google scholar: lookup
  32. Mohanty N, Gulati BR, Kumar R, Gera S, Kumar P, Somasundaram RK, Kumar S. Immunophenotypic characterization and tenogenic differentiation of mesenchymal stromal cells isolated from equine umbilical cord blood.. In Vitro Cell Dev Biol Anim 2014 Jun;50(6):538-48.
    pubmed: 24414976doi: 10.1007/s11626-013-9729-7google scholar: lookup
  33. Liu ZJ, Zhuge Y, Velazquez OC. Trafficking and differentiation of mesenchymal stem cells.. J Cell Biochem 2009 Apr 15;106(6):984-91.
    pubmed: 19229871doi: 10.1002/jcb.22091google scholar: lookup
  34. Baer PC. Adipose-derived mesenchymal stromal/stem cells: An update on their phenotype in vivo and in vitro.. World J Stem Cells 2014 Jul 26;6(3):256-65.
    pmc: PMC4131268pubmed: 25126376doi: 10.4252/wjsc.v6.i3.256google scholar: lookup
  35. Ranera B, Ordovás L, Lyahyai J, Bernal ML, Fernandes F, Remacha AR, Romero A, Vázquez FJ, Osta R, Cons C, Varona L, Zaragoza P, Martín-Burriel I, Rodellar C. Comparative study of equine bone marrow and adipose tissue-derived mesenchymal stromal cells.. Equine Vet J 2012 Jan;44(1):33-42.
    pubmed: 21668489doi: 10.1111/j.2042-3306.2010.00353.xgoogle scholar: lookup
  36. Lange-Consiglio A, Corradetti B, Rutigliano L, Cremonesi F, Bizzaro D. In vitro studies of horse umbilical cord matrix-derived cells: From characterization to labeling for magnetic resonance imaging.. Open Tissue Eng Regen Med J 2011;4:120–133.
  37. Raabe O, Shell K, Würtz A, Reich CM, Wenisch S, Arnhold S. Further insights into the characterization of equine adipose tissue-derived mesenchymal stem cells.. Vet Res Commun 2011 Aug;35(6):355-65.
    pubmed: 21614641doi: 10.1007/s11259-011-9480-zgoogle scholar: lookup
  38. Stolzing A, Jones E, McGonagle D, Scutt A. Age-related changes in human bone marrow-derived mesenchymal stem cells: consequences for cell therapies.. Mech Ageing Dev 2008 Mar;129(3):163-73.
    pubmed: 18241911doi: 10.1016/j.mad.2007.12.002google scholar: lookup
  39. Delling U, Lindner K, Ribitsch I, Jülke H, Brehm W. Comparison of bone marrow aspiration at the sternum and the tuber coxae in middle-aged horses.. Can J Vet Res 2012 Jan;76(1):52-6.
    pmc: PMC3244288pubmed: 22754095

Citations

This article has been cited 9 times.
  1. Stage HJ, Trappe S, Söllig K, Trachsel DS, Kirsch K, Zieger C, Merle R, Aschenbach JR, Gehlen H. Multilineage Differentiation Potential of Equine Adipose-Derived Stromal/Stem Cells from Different Sources. Animals (Basel) 2023 Apr 15;13(8).
    doi: 10.3390/ani13081352pubmed: 37106915google scholar: lookup
  2. Trachsel DS, Stage HJ, Rausch S, Trappe S, Söllig K, Sponder G, Merle R, Aschenbach JR, Gehlen H. Comparison of Sources and Methods for the Isolation of Equine Adipose Tissue-Derived Stromal/Stem Cells and Preliminary Results on Their Reaction to Incubation with 5-Azacytidine. Animals (Basel) 2022 Aug 11;12(16).
    doi: 10.3390/ani12162049pubmed: 36009640google scholar: lookup
  3. Sharun K, Jambagi K, Kumar R, Gugjoo MB, Pawde AM, Tuli HS, Dhama K, Amarpal. Clinical applications of adipose-derived stromal vascular fraction in veterinary practice. Vet Q 2022 Dec;42(1):151-166.
    doi: 10.1080/01652176.2022.2102688pubmed: 35841195google scholar: lookup
  4. Alt EU, Schmitz C, Bai X. Perspective: Why and How Ubiquitously Distributed, Vascular-Associated, Pluripotent Stem Cells in the Adult Body (vaPS Cells) Are the Next Generation of Medicine. Cells 2021 Sep 3;10(9).
    doi: 10.3390/cells10092303pubmed: 34571951google scholar: lookup
  5. Jifcovici A, Solano MA, Fitzpatrick N, Findji L, Blunn G, Sanghani-Kerai A. Comparison of Fat Harvested from Flank and Falciform Regions for Stem Cell Therapy in Dogs. Vet Sci 2021 Jan 25;8(2).
    doi: 10.3390/vetsci8020019pubmed: 33503997google scholar: lookup
  6. Haenel A, Ghosn M, Karimi T, Vykoukal J, Shah D, Valderrabano M, Schulz DG, Raizner A, Schmitz C, Alt EU. Unmodified autologous stem cells at point of care for chronic myocardial infarction. World J Stem Cells 2019 Oct 26;11(10):831-858.
    doi: 10.4252/wjsc.v11.i10.831pubmed: 31692971google scholar: lookup
  7. Arnhold S, Elashry MI, Klymiuk MC, Geburek F. Investigation of stemness and multipotency of equine adipose-derived mesenchymal stem cells (ASCs) from different fat sources in comparison with lipoma. Stem Cell Res Ther 2019 Oct 22;10(1):309.
    doi: 10.1186/s13287-019-1429-0pubmed: 31640774google scholar: lookup
  8. Longhini ALF, Salazar TE, Vieira C, Trinh T, Duan Y, Pay LM, Li Calzi S, Losh M, Johnston NA, Xie H, Kim M, Hunt RJ, Yoder MC, Santoro D, McCarrel TM, Grant MB. Peripheral blood-derived mesenchymal stem cells demonstrate immunomodulatory potential for therapeutic use in horses. PLoS One 2019;14(3):e0212642.
    doi: 10.1371/journal.pone.0212642pubmed: 30870461google scholar: lookup
  9. Ferreira-Baptista C, Ferreira R, Fernandes MH, Gomes PS, Colaço B. Influence of the Anatomical Site on Adipose Tissue-Derived Stromal Cells' Biological Profile and Osteogenic Potential in Companion Animals. Vet Sci 2023 Nov 24;10(12).
    doi: 10.3390/vetsci10120673pubmed: 38133224google scholar: lookup
Subscribe to our newsletter
Join 99,850 horse owners like you who receive our email updates on horse health and nutrition.